Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028363 · ClinicalTrials.gov registry record · Phase 3
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
A Phase 3 study of Acne Vulgaris, sponsored by Dermira.
- Completed
- Registry status
- Phase 3
- Development phase
- 759
- Enrollment target
- 20
- Study locations
NCT03028363: Completed Phase 3 study of Acne Vulgaris, sponsored by Dermira.
NCT03028363 is a Phase 3 study of Acne Vulgaris that has completed, run by Dermira. The registered enrollment target is 759 participants, above the 264-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (188% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028363, a Phase 3 study of Acne Vulgaris, has completed, sponsored by Dermira.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 759 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objectives of this study are to assess the safety and efficacy of Olumacostat Glasaretil Gel compared to vehicle in patients with acne vulgaris
Primary Outcome
Mean absolute change in acne lesion counts (inflammatory) from baseline to Week 12
Conditions Studied
Interventions
- DRUG Olumacostat Glasaretil Gel, 5.0%
- OTHER Olumacostat Glasaretil Gel, Vehicle
Study Locations (20)
Florida
- Finlay Medical Research - Miami
- Health Awareness, Inc - Port Saint Lucie
- International Clinical Research-US, LLC - Sanford
- Lenus Research & Medical Group - Sweetwater
- Research Institute of the Southeast, LLC - West Palm Beach
California
- Anaheim Clinical Trials - Anaheim
- Dermatology Research Associates - Los Angeles
- Rady Children's Hospital UCSD Pediatric and Adolescent Derm - San Diego
- University Clinical Trials Inc. - San Diego
Arizona
- Alliance Dermatology & MOHS Center - Phoenix
Colorado
- Horizons Clinical Research Center, LLC - Denver
Connecticut
- Dermatology Physicians of CT - Shelton
Illinois
- Arlington Dermatology - Arlington Heights
Indiana
- Forefront Dermatology - Carmel
Kansas
- Kansas City Dermatology, PA - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 759 participants |
| Start Date | 2016-12-27 |
| Est. Completion | 2017-11-28 |
| Phase | Phase 3 |
What the finished NCT03028363 record still lists
NCT03028363 is an interventional study that assigns participants to a tested intervention. The registered 759 participants enrollment target is mid-sized for trials with a published cap, above the 264-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (188% higher).
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 2 interventions - of which Olumacostat Glasaretil Gel, 5.0% is the first listed.
NCT03028363 names 20 study sites across 13 states, led by Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT03028363 about?
NCT03028363 is a clinical study titled "A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris". The objectives of this study are to assess the safety and efficacy of Olumacostat Glasaretil Gel compared to vehicle in patients with acne vulgaris
What is the current status of trial NCT03028363?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 759 participants. The study started on 2016-12-27. Estimated completion is 2017-11-28.
What conditions does trial NCT03028363 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT03028363?
The interventions under investigation include: Olumacostat Glasaretil Gel, 5.0% (DRUG), Olumacostat Glasaretil Gel, Vehicle (OTHER).
Who is sponsoring clinical trial NCT03028363?
This trial is sponsored by Dermira, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03028363 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03028363's enrollment target sits among peer trials
759 6th of 67 higher than 62 of 67 other Acne Vulgaris trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne Vulgaris trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
COMPLETED · Phase 3
-
A Study of S6G5T3 in the Treatment of Acne Vulgaris
COMPLETED · Phase 3
-
P3 Long Term Safety Study of Once Daily SB204 in Acne
COMPLETED · Phase 3
-
Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne
COMPLETED · Phase 3
-
Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
COMPLETED · Phase 3
-
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05129228 · 760 participants · NA
Optical Coherence Tomography of the Saphenous Vein Graft
- NCT05787821 · 760 participants
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI